Analyses of human gliomas by restriction landmark genomic scanning

Journal of Neuro-Oncology

Volumn 35, Issue 2, 1997, Pages 113-120

  Nakamura, Mitsutoshi ^a   Konishi, Noboru ^a   Tsunoda, Shigeru ^b   Hiasa, Yoshio ^a   Tsuzuki, Toshihide ^a   Aoki, Hideo ^a   Kobitsu, Kunihiko ^a   Nagai, Hisaki ^c   Sakaki, Toshisuke ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

^b Osaka Prefecture University   (Japan)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

Gel electrophoresis; Genetic subtypes; Glioblastoma; RLGS

Indexed keywords

CELL DNA;

ADULT; AGED; ALLELE; ARTICLE; ASTROCYTOMA; AUTORADIOGRAPHY; BRAIN TISSUE; CANCER GENETICS; CANCER GRADING; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; DNA METHYLATION; DNA SEQUENCE; FEMALE; GENE AMPLIFICATION; GENE DELETION; GENE REARRANGEMENT; GENETIC HETEROGENEITY; GLIOBLASTOMA; GLIOMA; HUMAN; HUMAN CELL; MALE; TUMOR CELL; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ASTROCYTOMA; DNA METHYLATION; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GENOME, HUMAN; GLIOBLASTOMA; HUMANS; RETROSPECTIVE STUDIES;

EID: 0030795207     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005712308061     Document Type: Article

References (36)

1. Ahmed Rasheed BK, Mclendon RE, Friedman HS, Friedman AH, Fuchs HE, Bigner DD, Bigner SH: Chromosome 10 deletion mapping in human gliomas: A common deletion region in 10q25. Oncogene 10: 2243-2246, 1995
2. El-Azouzi M, Chung RY, Farmer GE, Martuza RL, Black PM, Rouleau GA, Hettlich C, Hedley-Whyte ET, Zervas NT, Panagopoulos K, Nakamura Y, Gusella JF, Seizinger BR: Loss of distinct regions on the short arm of chromosome 17 associated with tumorigenesis of human astrocytomas. Proc Natl Acad Sci USA 86: 7186-7190, 1989
3. Fults D, Brockmeyer D, Tullous MW, Pedone CA, Cawthon RM: p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression. Cancer Res 52: 674-679, 1992
4. Henson JW, Schnitker BL, Correa KM, von Deimling A, Fassbender F, Xu H-J, Benedict WF, Yandell DW, Louis DN: The retinoblastoma gene is involved in malignant progression of astrocytomas. Ann Neurol 36: 714-721, 1994
5. Herman JG, Merlo A, Mao L, Lapidus RG, Issa JP, Davidson NE, Sidransky D, Baylin SB: Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res 55: 4525-4530, 1995
6. Hirvonen HE, Salonen R, Sandberg MM, Vuorio E, Västrik I, Kotilainen E, Kalimo H: Differential expression of myc, max and RB1 genes in human gliomas and glioma cell lines. Br J Cancer 69: 16-25, 1994
7. Kinzler KW, Bigner SH, Bigner DD, Trent JM, Law ML, O'Brien SJ, Wong AJ, Vogelstein B:Identification of an amplified, highly expressed gene in a human glioma. Science 23: 70-73, 1987
8. Kumabe T, Sohma Y, Kayama T, Yoshimoto T, Yamamoto T: Amplification of alpha-platelet-derived growth factor receptor gene lacking an exon coding for a portion of the extracellular region in a primary brain tumor of glial origin. Oncogene 7: 627-633, 1992
9. Lang FF, Miller DC, Koslow M, Newcomb E: Pathways leading to glioblastoma multiforme: A molecular analysis of genetic alteration in 65 astrocytic tumors. J Neurosurg 81: 427-436, 1994
10. Liberman TA, Nusbaum HR, Razon N, Kris R, Lax I, Soreq H, Whittle N, Waterfield MD, Ullrich A, Schlessinger J: Amplification, enhanced expression and possible rearrangment of EGF receptor gene in primary human brain tumours of glial origin. Nature 313: 144-147, 1985
11. Nakamura M, Konishi N, Hiasa Y, Tsunoda S, Fukushima Y, Tsuzuki T, Takemura K, Aoki H, Kobitsu K, Sakaki T: Immunohistochemical detection of CDKN2, retinoblastoma and p53 gene products in primary astrocytic tumors. Int J Oncol 8: 889-893, 1996
12. Reifenberger G, Liu L, Ichimura K, Schmidt EE, Collins VP: Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations. Cancer Res 53: 2736-2739, 1993
13. Schmidt EE, Ichimura K, Reifenberger G, Collins VP: CDKN2 (p16/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas. Cancer Res 54: 6321-6324, 1994
14. Tsuzuki T, Tsunoda S, Sakaki T, Konishi N, Hiasa Y, Nakamura M: Alterations of RB, p53, p16 (CDKN2), and p15 genes in human astrocytomas. Cancer 78: 287-293, 1996
15. Ueki K, Ono Y, Henson JW, Efird JT, von Deimling A, Louis DN: CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated. Cancer Res 56: 150-153, 1996
16. Venter DJ, Thomas DGT: Multiple sequential molecular abnormalities in the evolution of human gliomas. Br J Cancer 63: 753-757, 1991
17. von Deimling A, von Ammon K, Schoenfeld D, Wiertler OD, Seizinger BR, Louis DN: Subsets of glioblastoma multiforme defined by molecular genetic analysis. Brain Pathol 3: 19-26, 1993
18. Wong AJ, Bigner SH, Bigner DD, Kinzler KW, Hamilton SR, Vogelstein B: Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification. Proc Natl Acad Sci USA 84: 6899-6903, 1987
19. Hatada I, Hayashizaki Y, Hirotsune S, Komatsubara H, Mukai T: A genomic scanning method for higher organisms usingrestriction sites as landmarks. Proc Natl Acad Sci USA 88: 9523-9527, 1991
20. Hirotsune S, Hatada I, Komatsubara H, Nagai H, Kuma K, Kobayakawa K, Kawara T, Nakagawara A, Fujii K, Mukai T, Hayashizaki Y: New approach for detection of amplification in cancer DNA using restriction landmark genomic scanning. Cancer Res 52: 3642-3647, 1992
21. Nagai H, Hirotsune S, Komatsubara H, Hatada I, Mukai T, Hayashizaki Y, Matsubara K: Genomic analysis of human hepatocellular carcinomas using restriction landmark genomic scanning. Cancer Detect Prev 17: 399-404, 1993
22. Asakawa J, Kuick R, Neel JV, Kodaira M, Satoh C, Hanash SM: Genetic variation detected by quantitative analysis of end-labeled genomic DNA fragments. Proc Natl A cad Sci USA 91: 9052-9056, 1994
23. Konishi N, Hiasa Y, Nakamura M, Kitahori Y, Matsubara K, Nagai H: Different patterns of DNA alterations detected by restriction landmark genomic scanning in heterogeneous prostate carcinomas. Am J Pathol (in press)
24. Kuick R, Asakawa J, Neel JV, Satoh C, Hanash SM: High yield of restriction fragment length polymorphisms in two-dimensional separations of human genomic DNA. Genomics 25: 345-353, 1995
25. Okazaki Y, Hirose K, Hirotsune S, Okuizumi H, Sasaki N, Ohsumi T, Yoshiki A, Kusakabe M, Muramatsu M, Kawai J, Watanabe S, Plass C, Chapman VM, Nakao K, Katsuki M, Hayashizaki Y: Direct detection and isolation of restriction landmark genomic scanning (RLGS) spot DNA markers tightly linked to a specific trait by using the RLGS spot-bombing method. Proc Natl Acad Sci USA 92: 5610-5614, 1995
26. Nagai H, Ponglikitmongkol M, Mita E, Ohmachi Y, Yoshikawa H, Saeki R, Yumoto Y, Nakanishi T, Matsubara K: Aberration of genomic DNA in association with human hepatocellular carcinomas detected by 2-dimensional gel analysis. Cancer Res 54: 1545-1550, 1994
27. Nagai H, Tsumura H, Ponglikitmongkol M, Kim YS, Matsubara K: Genomic aberrations in human hepatoblastomas detected by 2-dimensional gel analysis. Cancer Res 55: 4549-4551, 1995
28. Nagai H, Ponglikitmongkol M, Kim YS, Yoshikawa H, Matsubara K: Cloning of Not I-cleaved genomic DNA fragments appearing as spots in 2D gel electrophoresis. Biochem Biophys Res Commun 213: 258-265, 1995
29. Hayashizaki Y, Hirotsune S, Okazaki Y, Shibata H, Akasako A, Muramatsu M, Kawai J, Hirasawa T, Watanabe S, Shiroishi T, Moriwaki K, Taylor BA, Matsuda Y, Elliott RW, Manly KF, Chapman VM: A genetic linkage map of the mouse using restriction landmark genomic scanning (RLGS). Genetics 138: 1207-1238, 1994
30. Hayashizaki Y, Shibata H, Hirotsune S, Sugino H, Okazaki Y, Sasaki N, Hirose K, Imoto H, Okuizumi H, Muramatsu M, Komatsubara H, Shiroishi T, Moriwaki K, Katsuki M, Hatano N, Sasaki H, Ueda T, Mise N, Takagi N, Plass C, Chapman VM: Identification of an imprinted U2af binding protein related sequence on mouse chromosome 11 using the RLGS method. Nat Genet 6: 33-40, 1994
31. Kawai J, Hirose K, Fushiki S, Hirotsune S, Ozawa N, Hara A, Hayashizaki Y, Watanabe S: Comparison of DNA methylation patterns among mouse cell lines by restriction land-mark genomic scanning. Mol Cell Biol 14: 7421-7427, 1994
32. Kleihues P, Burger PC, Scheithauer BW: Histological Typing of Tumours of the Central Nervous System. Springer-Verlag, Berlin, Germany, 1993
33. Blin N, Stafford DW: A general method for isolation of high molecular weight DNA from eukaryotes. Nucleic Acids Res 3: 2303-2308, 1976
34. Hirotsune S, Hirose K, Kataoka H, Kuromitsu J, Furuichi Y, Muramatsu M, Matsuda Y, Hayashizaki Y: Spot mapping on the standard profile of restriction landmark genomic scanning (RLGS) of sorted chromosome 20 using methylation-insensitive enzyme. Genomics 24: 593-596, 1994
35. Makos M, Nelkin BD, Chazin VR, Cavenee WK, Brodeur GM, Baylin SB: DNA hypermethylation is associated with 17p allelic loss in neural tumors. Cancer Res 53: 2715-2718, 1993
36. Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC, Baylin SB, Sidransky D: 5′ CpG Island methylation is associated with transcriptional silencing of the tumor suppressor p16/CDKN2/MTS1 in human cancers. Nature Med 1: 686-692, 1995